Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
35,650
+2,050 (6.10%)
Apr 1, 2025, 3:30 PM KST
Mezzion Pharma Revenue
In the year 2024, Mezzion Pharma had annual revenue of 8.61B KRW, down -72.85%. Mezzion Pharma had revenue of 1.92B in the quarter ending December 31, 2024, a decrease of -73.96%.
Revenue
8.61B
Revenue Growth
-72.85%
P/S Ratio
123.47
Revenue / Employee
506.57M
Employees
17
Market Cap
1,068.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.61B | -23.11B | -72.85% |
Dec 31, 2023 | 31.72B | 994.76M | 3.24% |
Dec 31, 2022 | 30.73B | 4.07B | 15.28% |
Dec 31, 2021 | 26.65B | -1.98B | -6.92% |
Dec 31, 2020 | 28.63B | 10.71B | 59.79% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Celltrion | 3,557.30B |
Kia Corporation | 107.45T |
KB Financial Group | 15.01T |